Athira Pharma, Inc. (ATHA) Earnings History
Net Loss8 years of earnings data (2018–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Athira Pharma, Inc. (ATHA) Earnings Overview
As of June 24, 2026, Athira Pharma, Inc. (ATHA) reported trailing twelve-month net income of -$129M, reflecting +2.0% year-over-year growth. The company earned $-6.80 per diluted share over the past four quarters.
Looking at the long-term picture, ATHA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$5M in fiscal 2018.
Athira Pharma, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SAVA (-$106M net income), ACIU (-$70M net income, -1971.6% margin), PRAX (-$327M net income), ATHA has comparable earnings metrics. Compare ATHA vs SAVA →
ATHA Earnings vs Peers
Earnings metrics vs comparable public companies
ATHA Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$106M | -8.9% | -$102M | $-24.70 | - | - |
| 2024 | -$97M | +17.6% | -$101M | $-25.20 | - | - |
| 2023 | -$118M | -23.0% | -$125M | $-30.90 | - | - |
| 2022 | -$96M | -74.4% | -$104M | $-25.30 | - | - |
| 2021 | -$55M | -174.9% | -$64M | $-14.90 | - | - |
| 2020 | -$20M | -286.6% | -$20M | $-6.10 | - | - |
| 2019 | -$5M | -1.3% | -$5M | $-1.40 | - | - |
| 2018 | -$5M | - | -$5M | $-1.60 | - | - |
Download Data
Export ATHA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ATHA — Frequently Asked Questions
Quick answers to the most common questions about buying ATHA stock.
What is ATHA earnings per share (EPS)?
ATHA trailing twelve-month (TTM) diluted EPS is $-6.80, reflecting +2.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is Athira Pharma, Inc.'s net income?
Athira Pharma, Inc. (ATHA) trailing twelve-month net income is $-129M as of 2025. Earnings grew +2.0% year-over-year.
Is ATHA profitable?
ATHA is not currently profitable on a TTM basis, reporting a net loss of $-129M. Net margin is N/A. Investors should monitor for a return to profitability.
What is ATHA's earnings growth rate?
ATHA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are ATHA's profit margins?
Athira Pharma, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -290.8%.
Is ATHA growing earnings?
ATHA earnings growth is slowing. Current YoY EPS growth of +2.0% trails the 5-year CAGR of N/A. TTM net income is $-129M.
What was ATHA's best earnings year?
Athira Pharma, Inc.'s highest annual net income on record is $-5M, achieved in fiscal year 2018. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were ATHA's earnings last quarter?
ATHA's most recent reported quarter was Q1 2026. Net income was $-33M with diluted EPS of $-1.73. For a full breakdown of all quarters, see the quarterly earnings table on this page.